Cart
sales@molnova.com
MN-25
CAS No. 501926-82-5
MN-25 ( MN 25;AR-12;AR 12 )
Catalog No. M14692 CAS No. 501926-82-5
A potent, reasonably selective agonist of peripheral cannabinoid receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMN-25
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, reasonably selective agonist of peripheral cannabinoid receptor.
-
DescriptionA potent, reasonably selective agonist of peripheral cannabinoid receptor with Ki of 11 nM for CB2, 22-fold selectivity over the psychoactive CB1 receptors (Ki=245 nM).
-
SynonymsMN 25;AR-12;AR 12
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number501926-82-5
-
Formula Weight439.59
-
Molecular FormulaC26H37N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C2CCC(C2)(C1NC(=O)C3=CN(C4=C3C=CC=C4OC)CCN5CCOCC5)C)C
-
Chemical NameN-[(S)-Fenchyl]-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wrobleski ST, et al. J Med Chem. 2003 May 22;46(11):2110-6.
2. Hynes J Jr, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2399-402.
2. Hynes J Jr, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2399-402.
molnova catalog
related products
-
Alismoxide
Alismoxide has anti-inflammatory effects.
-
Otenabant
A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively; has low affinity (Ki=7600 nM) for human CB2 receptors; reverses cannabinoid agonist mediated responses, reduces food intake, and increases energy expenditure and fat oxidation in rodents.ObesityPhase 3 Discontinued
-
AM-6538
AM-6538 (AM6538) is a potent, selective cannabinoid receptor CB1 antagonist with Ki of 5.1 nM.
